Abstract
BACKGROUND: Proton pump inhibitors (PPIs) are widely used drugs for the treatment of many diseases. Prolonged use was believed to have an effect on bone mineral metabolism. OBJECTIVE: To investigate the effect of PPIs on bone mineral density and to identify risk factors affecting bone mineral density among users of PPIs. PATIENTS AND METHODS: A cross sectional study was conducted in Rheumatology Consultancy Clinic of Baghdad Teaching Hospital /Baghdad Medical City during the period from 1st of November, 2017 to 31st of October, 2018 on convenient sample of 100 patients were selected; first group was 50 PPI users and 50 PPI non-users. The bone mineral density of patients was assessed using dual energy x-ray absorptiometry (DXA) scan. RESULTS: A significant reduction in serum calcium, vitamin D and serum inorganic phosphorus levels of PPIs users with elevated level of alkaline phosphatase activity. All scores of DXA scan like T-scores L2-L4, Z-scores L2-L4 and total scores were significantly reduced among PPIs users in comparison to PPIs-non users (P<0.05). CONCLUSION: The proton pump inhibitors have a profound effect on bone mineral density and long term use of proton pump inhibitors is commonly related with osteoporosis and osteopenia development of lumbar spines.
Recommended Citation
Shandookh, Qusay; Albedri, Khudair; and Abdullateef, Nada
(2021)
"Effect of Chronic Use of Proton Pump Inhibitors on Bone Mineral Density,"
Iraqi Postgraduate Medical Journal: Vol. 21:
Iss.
2, Article 15.
DOI: 10.52573/ipmj.2021.174635
Available at:
https://ipmj.researchcommons.org/journal/vol21/iss2/15
DOI
10.52573/ipmj.2021.174635